ArticleFrontiers in medicine2025
Endovascular repair with covered stent for a giant hepatic artery pseudoaneurysm: a case report and literature review.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hepatic artery pseudoaneurysm (HAP), a rare life-threatening complication, typically occurs following trauma or surgical procedures such as liver transplantation. Initially asymptomatic, its rupture risk escalates with increasing size. Once ruptured, it carries an extremely high mortality rate, and delayed intervention may lead to fatal hemorrhagic shock. Consequently, early diagnosis and timely intervention are pivotal in managing HAP. Herein, we present a case of a HAP measuring approximately 10 cm in diameter. The patient was admitted with abdominal pain, and the clinical history did not indicate a definitive etiology. Computed tomography angiography revealed that the rupture site of the pseudoaneurysm was located in the common hepatic artery, with partial thrombus formation within the aneurysmal sac. The expansive lesion compressed the hepatic artery, resulting in hypoperfusion. Following multidisciplinary consultation and obtaining informed consent from the patient and her family, the patient underwent endovascular treatment under local anesthesia. During the procedure, two covered stents were successfully implanted. Postoperatively, the rupture of the HAP was effectively excluded, hepatic arterial patency was restored, and the patient's abdominal pain was alleviated significantly. She was discharged 5 days after receiving antiplatelet and anti-infective therapy. Long-term antiplatelet treatment was continued, and at a one-year follow-up, the stent remained patent with no evidence of lesion recurrence. This case report, combined with literature review, aims to analyze HAP etiology and summarize diagnostic and therapeutic experiences.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.